Tin t&#x1EE9;c &amp; C&#x1EAD;p nh&#x1EAD;t

Smoking daily may cause the brain to shrink in a dose-response manner, and quitting does not seem to reverse the brain volume loss, as reported in a study.

Daily smoking linked to smaller brains

Most HF patients do not undergo loop diuretic dose reduction after SGLT2i initiation

Majority of the patients with heart failure (HF) who have initiated treatment with sodium-glucose cotransporter 2 inhibitor (SGLT2i) show no change in loop diuretic dose, reports a study.

Most HF patients do not undergo loop diuretic dose reduction after SGLT2i initiation

19 Dec 2023

Smartphone-based intervention helps improve mental health of university students

Mobile Mindfulness Meditation (MMM) demonstrates effectiveness in reducing stress and anxiety among university students, leading to better mental health, according to a study.

Smartphone-based intervention helps improve mental health of university students

19 Dec 2023

Antipsychotic use for amphetamine-induced psychosis tied to longer hospital stay

Patients with amphetamine-induced psychosis (AIP) who have been treated with antipsychotics appear to have a longer length of stay (LOS) than those who did not receive such treatment, reports a study.

Antipsychotic use for amphetamine-induced psychosis tied to longer hospital stay

Real-world data highlight tofacitinib potential for irAE management in cancer patients

In a study presented at ESMO Asia 2023, tofacitinib, a rapidly acting JAK-STAT inhibitor with reported efficacy in the treatment of various autoimmune diseases, was effective for the management of difficult-to-treat immune-related adverse events (irAEs) and was well-tolerated in cancer patients, with only a few patients developing infectious events.

Real-world data highlight tofacitinib potential for irAE management in cancer patients

Pregnancy after breast cancer safe for BRCA carriers

One in five young BRCA carriers with breast cancer subsequently conceive within 10 years, without any detrimental effect on disease-free survival, according to a study.

Pregnancy after breast cancer safe for BRCA carriers

19 Dec 2023

Add-on PCSK9 inhibitor cuts LDL-C by half, allows infrequent dosing in patients maxed out on statins

Injection with the novel, long-acting PCSK9 inhibitor recaticimab once every 3 months reduces LDL-cholesterol (LDL-C) levels by >50 percent compared with placebo in patients already maxed out on statins in the phase III REMAIN-2 trial.

Add-on PCSK9 inhibitor cuts LDL-C by half, allows infrequent dosing in patients maxed out on statins

Even seemingly healthy teens with high BMI at risk of early CKD

High body mass index (BMI) in late adolescence appears to be a risk factor for chronic kidney disease (CKD) in young adulthood, even for seemingly healthy individuals with a BMI that falls within the normal range but is closer to the upper limit, as reported in a study.

Even seemingly healthy teens with high BMI at risk of early CKD

Real-world data favour etelcalcetide for treating SHPT in multiethnic Asians

18 Dec 2023 bởi

Etelcalcetide proves beneficial in the real-world treatment of secondary hyperparathyroidism (SHPT) in multiethnic Asian haemodialysis patients, with the added advantage of reducing pill burden, as shown in a study from Singapore.

Real-world data favour etelcalcetide for treating SHPT in multiethnic Asians

What prevents patients from receiving a COVID-19 vaccine?